Search Results 861-870 of 18332 for Hepatitis b

1. Safety and Efficacy of IMM 124-E for Patients with Severe Alcoholic Hepatitis - Mayo Clinic

   ... hepatitis (SAH). Aim: To perform a phase 2a "proof of concept" placebo-controlled, dose-ranging study of Imm 124-E (hyperimmune bovine colostrum enriched ...

2. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   Untreated chronic hepatitis B or chronic hepatitis B virus (HBV) carriers with HBV DNA > 500 IU/mL (or > 2500 copies/mL) or active hepatitis C at screening:.

3. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma - Mayo Clinic

   b. To evaluate overall survival in patients with resectable malignant ... hepatitis B virus (HBV) infection as evidenced by testing performed within 28 ...

4. PR3-AAV Resilient Remission or PRRR - Clinical Trials

   - Infection (blood borne): active hepatitis B or active hepatitis C or a documented history of HIV, hepatitis B, or hepatitis C. - Infection (history): ...

5. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   * HBV immune participants (ie, being hepatitis B surface antigen [HBsAg] negative and hepatitis B antibody positive) may be included, however. Has any ...

6. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

   line with local practice), hepatitis B (known positive HBV surface antigen [HBsAg] result), hepatitis C, or human immunodeficiency virus (positive HIV 1/2 ...

7. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

   ... B-cell lymphoma. Participation ... History of human immunodeficiency virus (HIV) infection or acute or chronic active hepatitis B or hepatitis C infection.

8. Light Chain Amyloidosis Maintenance Evaluation - Mayo Clinic

   Seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). NOTE: Subjects with resolved infection (i.e., subjects ...

9. Teresa B. Jensen, M.D. - Doctors and Medical Staff - Mayo Clinic

   ResidentFamily Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

10. A Study of Vascular Dysfunction in Polycystic Kidney Disease (PKD) - Mayo Clinic

    Concomitant systemic disease in the kidney (e.g., lupus, hepatitis B or C, amyloidosis, glomerular disease). Diabetes mellitus trea tment with insulin or ...